Fulfilling our goals will contribute to society
Mission Statement
The goal of the Nippon Chemiphar Group is to make a difference in society by providing pharmaceutical drugs and health-related services to help people become and remain healthy.
Nippon Chemiphar’s Three Plus 1 Principal Goals
Since 2000, Nippon Chemiphar has promoted a basic management strategy based on three goals: establishing a strong presence in the generics business; becoming a leader in the field of alkalization therapy; and pursuing in-house drug discovery and development.
To attain these three goals, we are working to increase our earnings capacity through the generic drugs business; deploying multilaterally the additional business foundation we are building by leveraging our alkalization therapy expertise, cultivated through Uralyt; and striving to secure further growth, over the medium to long term, through in-house drug discovery and in-licensing of new drugs.
We believe that these efforts will enable us to maximize the value of our corporate Group and achieve sustainable growth as we combine businesses that are advancing on different time horizons, as well as duplicate overseas the results that these businesses generate in Japan.
